Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer R Keole

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
A Prospective Trial of Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Integrated Boost for Prostate Cancer: Long-term Outcomes Compared With Standard Image Guided IMRTMichael H Schild, Steven E Schild, William W Wong, et al.
American Journal of Clinical Oncology|February 7, 2020
ACR-ASTRO Practice Parameter for the Performance of Proton Beam Radiation TherapyHelen A Shih, Ramesh Rengan, Smith Apisarnthanarax, et al.
Advances in Radiation Oncology|September 12, 2018
Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancerCarlos E Vargas, Matthew Q Schmidt, Joshua R Niska, et al.
Radiation Oncology (London, England)|June 19, 2019
Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protonsYixiu Kang, Jiajian Shen, Wei Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2017
Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured PatientsMark R Waddle, Terence T Sio, Holly K Van Houten, et al.
Practical Radiation Oncology|April 8, 2023
First Report On Physician Assessment and Clinical Acceptability of Custom-Retrained Artificial Intelligence Models for Clinical Target Volume and Organs-at-Risk Auto-Delineation for Postprostatectomy PatientsDean Hobbis, Nathan Y Yu, Karl W Mund, et al.
Advances in Radiation Oncology|March 10, 2023
Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003Brady S Laughlin, Cameron S Thorpe, Todd A DeWees, et al.
Practical Radiation Oncology|August 25, 2019
Minimum Data Elements for Radiation Oncology: An American Society for Radiation Oncology Consensus PaperJames A Hayman, Andre Dekker, Mary Feng, et al.
Cancers|January 8, 2023
Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image GuidanceBrady S Laughlin, Nathan Y Yu, Stephanie Lo, et al.
Radiation Oncology Journal|October 8, 2021
Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapyGabriella F Bulman, Ronik S Bhangoo, Todd A DeWees, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
A Prospective Trial of Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Integrated Boost for Prostate Cancer: Long-term Outcomes Compared With Standard Image Guided IMRTMichael H Schild, Steven E Schild, William W Wong, et al.
American Journal of Clinical Oncology|February 7, 2020
ACR-ASTRO Practice Parameter for the Performance of Proton Beam Radiation TherapyHelen A Shih, Ramesh Rengan, Smith Apisarnthanarax, et al.
Advances in Radiation Oncology|September 12, 2018
Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancerCarlos E Vargas, Matthew Q Schmidt, Joshua R Niska, et al.
Radiation Oncology (London, England)|June 19, 2019
Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protonsYixiu Kang, Jiajian Shen, Wei Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2017
Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured PatientsMark R Waddle, Terence T Sio, Holly K Van Houten, et al.
Practical Radiation Oncology|April 8, 2023
First Report On Physician Assessment and Clinical Acceptability of Custom-Retrained Artificial Intelligence Models for Clinical Target Volume and Organs-at-Risk Auto-Delineation for Postprostatectomy PatientsDean Hobbis, Nathan Y Yu, Karl W Mund, et al.
Advances in Radiation Oncology|March 10, 2023
Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003Brady S Laughlin, Cameron S Thorpe, Todd A DeWees, et al.
Practical Radiation Oncology|August 25, 2019
Minimum Data Elements for Radiation Oncology: An American Society for Radiation Oncology Consensus PaperJames A Hayman, Andre Dekker, Mary Feng, et al.
Cancers|January 8, 2023
Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image GuidanceBrady S Laughlin, Nathan Y Yu, Stephanie Lo, et al.
Radiation Oncology Journal|October 8, 2021
Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapyGabriella F Bulman, Ronik S Bhangoo, Todd A DeWees, et al.
Pageof 7